This white paper looks at how donor-derived cell-free DNA (dd-cfDNA) is a useful analyte to detect allograph injury and rejection. More widespread monitoring of dd-cfDNA can help improve long-term organ transplant outcomes.
This white paper is designed to provide education for laboratory professionals and clinicians interested in assessing molecular technologies to better manage their patients. Select the link below to read it in full.
Download
Download & Print ❯
Resources
View search results for more transplantation related articles.
Scientific Research ❯
Related Products
LABScreen COVID Plus ❯
LabScreen Single Antigen ❯
Related Links
Coronavirus disease (COVID-19) training: Online training ❯
COVID-19 vs. SARS: How Do They Differ? ❯